Figure 1.

A: Within-group proportions of MAT receipt among treatment episodes with heroin or other opioids reported as primary substances at treatment admission; Treatment episodes with dual mental health disorders in expansion states (TEDS-D, 2012–2017, n=398,155). Fig. 1B: Within-group proportions of MAT receipt among treatment episodes with heroin or other opioids reported as primary substances at treatment admission; Treatment episodes without dual mental health disorders in expansion states (TEDS-D, 2012–2017, n=755,827). Fig. 1C: Within-group proportions of MAT receipt among treatment episodes with heroin or other opioids reported as primary substances at treatment admission; Treatment episodes with dual mental health disorders in non-expansion states (TEDS-D, 2012–2017, n=88,201). Fig. 1D: Within-group proportions of MAT receipt among treatment episodes with heroin or other opioids reported as primary substances at treatment admission; Treatment episodes without dual mental health disorders in non-expansion states (TEDS-D, 2012–2017, n=158,625).

Note:

Circle outline = American Indian/Alaska Native men

Circle filled = American Indian/Alaska Native women

Square outline = Black men

Square filled = Black women

Star outline = Hispanic men

Star outline = Hispanic women

Diamond outline = White men

Diamond filled = White women